Teva faces fresh antitrust scrutiny, this time via competition probe in Turkey

Teva is increasingly highlighting its innovative drug bona fides these days, seeking to style itself as both a novel drug-producing biopharma and a generics powerhouse.  | Teva is increasingly highlighting its innovative drug bona fides these days, seeking to style itself as both a novel drug-producing biopharma and a generics powerhouse.